Nalaganje...
HER2-/HER3-Targeting Antibody—Drug Conjugates for Treating Lung and Colorectal Cancers Resistant to EGFR Inhibitors
SIMPLE SUMMARY: Epidermal growth factor receptor (EGFR) is one of the anticancer drug targets for certain malignancies including nonsmall cell lung cancer (NSCLC), colorectal cancer (CRC), and head and neck squamous cell carcinoma. However, the grave issue of drug resistance through diverse mechanis...
Shranjeno v:
| izdano v: | Cancers (Basel) |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7958627/ https://ncbi.nlm.nih.gov/pubmed/33801379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051047 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|